Levodopa in EArly Parkinson's disease: A prospective, randomized, double blind, placebo-controlled, delayed start trial
Phase of Trial: Phase III
Latest Information Update: 04 Jan 2018
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms LEAP
- 02 Jan 2018 Status changed from active, no longer recruiting to completed.
- 17 May 2016 Status changed from withdrawn prior to enrolment to active, no longer recruiting.
- 31 Mar 2016 Planned End Date changed from 1 Jun 2016 to 31 Dec 2017 as per ISRCTN: Current Controlled Trials record.